# The Role of Negative-Pressure Wound Therapy in Patients with Fracture-Related Infection: A Systematic Review and Critical Appraisal

Authors: Susan Haidari; Frank F. A. IJpma; Willem-Jan Metsemakers; Wies Maarse; H. Charles Vogely; Alex J. Ramsden; Martin A. McNally; Geertje A. M. Govaert
Journal: BioMed Research International
 (2021)

---

## Abstract

Introduction. Fracture-related infection (FRI) is a severe musculoskeletal complication in orthopedic trauma surgery, causing challenges in bony and soft tissue management. Currently, negative-pressure wound therapy (NPWT) is often used as temporary coverage for traumatic and surgical wounds, also in cases of FRI. However, controversy exists about the impact of NPWT on the outcome in FRI, specifically on infection recurrence. Therefore, this systematic review qualitatively assesses the literature on the role of NPWT in the management of FRI. Methods. A literature search of the PubMed, Embase, and Web of Science database was performed. Studies that reported on infection recurrence related to FRI management combined with NPWT were eligible for inclusion. Quality assessment was done using the PRISMA statement and the Newcastle-Ottawa Quality Assessment Scale. Results. After screening and quality assessment of 775 unique identified records, eight articles could be included for qualitative synthesis. All eight studies reported on infection recurrence, which ranged from 2.8% to 34.9%. Six studies described wound healing time, varying from two to seven weeks. Four studies took repeated microbial swabs during subsequent vacuum dressing changes. One study reported newly detected pathogens in 23% of the included patients, and three studies did not find new pathogens. Conclusion. This review provides an assessment of current literature on the role of NPWT in the management of soft tissue defects in patients with FRI. Due to the lack of uniformity in included studies, conclusions should be drawn with caution. Currently, there is no clear scientific evidence to support the use of NPWT as definitive treatment in FRI. At this stage, we can only recommend early soft tissue coverage (within days) with a local or free flap. NPWT may be safe for a few days as temporarily soft tissue coverage until definitive soft tissue management could be performed. However, comparative studies between NPWT and early wound closure in FRI patients are needed.


---

## Body

## 1. Introduction

Fracture-related infection (FRI) [1] is a severe complication in trauma surgery. It can delay bone and soft tissue healing and lead to persistent disability, with an overall reported treatment failure (e.g., amputation of the infected limb, recurrent infection) of 4-11% [2–5]. With a reported FRI rate up to 25-30% [6] in complex injuries, this condition has both a major personal and societal impact [7, 8]. Even after surgically successful treatment of FRI, patients report lower quality of life [9]. Healthcare costs for patients with infections are significantly higher compared to noninfected patients, mostly due to prolonged hospitalization [10–12], and the fact that patients often undergo multiple surgeries. With an increasing prevalence of FRI, this indicates an upcoming challenge for healthcare systems [13].Recently, an international expert group developed guidelines promoting a structured treatment approach for FRI, primarily based on the concept of thorough surgical debridement with dead space management, stabilization of the fracture (if needed), and robust soft tissue coverage followed by adequate antibiotic therapy [14]. Meticulous surgical excision of all nonviable tissue is however often associated with the inevitable creation of significant soft tissue defects. Since the Food and Drug Administration approval in 1995, the application of negative-pressure wound therapy (NPWT) is increasingly popular for the temporary coverage of complex traumatic wounds [15]. Using this technique, a sterile, open cell foam or gauze dressing is applied on the soft tissue defect and connected through suction tubes to a vacuum pump and liquid waste collector. A controlled negative pressure in a range from -50 to -125 mmHg can be applied constantly or intermittently [16]. In acute open traumatic wounds with fractures, coverage with NPWT is believed to prevent ongoing contamination of the wound and to help maintain a moist environment. It can therefore temporarily be applied as a bridging method until definitive wound coverage is performed [17].However, scientific evidence on its effect on the recurrence rate and treatment of FRI is conflicting. On one hand, NPWT is claimed to remove residual bacteria and to encourage granulation tissue [18–20] and new blood vessel formation in traumatic wounds and open fractures [21], leading to faster wound healing and reduction of complications [19]. On the other hand, studies reported that NPWT does not reduce the incidence of infection compared to standard dressing techniques in open fractures [22]. Furthermore, it was demonstrated that NPWT did not reduce the bacterial load [23] of involved wounds. In fact, some authors even reported an increased bacterial colonization [24]. Also, a previous evidence-based review of NPWT states its use in “untreated osteomyelitis is contraindicated” [25]. Therefore, the aim of this systematic review is to qualitatively assess the available medical literature on the role of NPWT in the management of established FRI.


## 2. Methods

### 2.1. Literature Search Strategy

This systematic review was performed according to the guidelines recommended by the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement [26] and its “Explanations and Elaboration” [27]. A computerized literature search was performed for published articles in the PubMed, Embase, and Web of Science databases. A final literature search was conducted at March 18th 2021. The search string included all synonyms for “negative pressure wound therapy” and “fracture related infection,” combined by “OR/AND.” The complete syntax is shown in Appendix I. In addition, references of included studies and reviews that were found in this search strategy were screened and, if relevant, added to this analysis. Duplicates were removed, and all titles and abstracts were screened by the first author (SH) according to the following inclusion and exclusion criteria. If eligibility was uncertain after title/abstract screening, the full text was assessed to judge if the inclusion criteria were met. Remaining uncertainties were resolved in a consensus meeting with a second reviewer (GG).


### 2.2. Inclusion Criteria

Articles were included in this analysis if(i)
The patient population was diagnosed with FRI according to the FRI consensus definition as shown in Figure1 [1, 28](ii)
NPWT was applied to the associated infected wound(iii)
The full article was available in the English, Dutch, or German languageFigure 1
Flowchart of confirmatory and suggestive criteria visualized by McNally et al. (2020), using the definition criteria of the FRI Consensus Group [42].


### 2.3. Exclusion Criteria

Articles were excluded from this analysis if(i)
The included study population (partly) consisted of patients with other disease entities than infected fractures (such as spondylodiscitis, diabetic feet, and pressure ulcers)(ii)
The study population concerned animals


### 2.4. Quality Assessment

The methodological quality of the selected studies was assessed using the Newcastle-Ottawa Quality Assessment Scale (NOS) [29], a tool used for assessing the quality of nonrandomized cohort and case control studies. The NOS consists of criteria organized into three categories: selection (maximum four stars), comparability (maximum two stars), and outcome (maximum three stars). A study can be awarded a maximum of nine stars. In this systematic review, an overall NOS score cutoff of ≥7 stars was defined as high quality and <7 stars as low quality. Criteria scored “N/A” were not taken into account. Only high-quality studies were included for further analysis.


### 2.5. Data Extraction and Analysis

From the high-quality papers, the following study characteristics were extracted: bibliography (first author, year of publication, country), study design, number of inclusions, patient demographics, cause of injury, type of pathogens, NPWT duration, additional treatment, final wound closure, and follow-up duration. The primary outcome was recurrence of infection.Secondary collected outcomes were wound healing time and detection of new (morphologically different) pathogens in follow-up swabs compared to the initial swab. Due to heterogeneity of studies and lack of reported outcomes, a meta-analysis could not be performed. The data was analyzed descriptively and classified according to the quality assessment.


## 2.1. Literature Search Strategy

This systematic review was performed according to the guidelines recommended by the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement [26] and its “Explanations and Elaboration” [27]. A computerized literature search was performed for published articles in the PubMed, Embase, and Web of Science databases. A final literature search was conducted at March 18th 2021. The search string included all synonyms for “negative pressure wound therapy” and “fracture related infection,” combined by “OR/AND.” The complete syntax is shown in Appendix I. In addition, references of included studies and reviews that were found in this search strategy were screened and, if relevant, added to this analysis. Duplicates were removed, and all titles and abstracts were screened by the first author (SH) according to the following inclusion and exclusion criteria. If eligibility was uncertain after title/abstract screening, the full text was assessed to judge if the inclusion criteria were met. Remaining uncertainties were resolved in a consensus meeting with a second reviewer (GG).


## 2.2. Inclusion Criteria

Articles were included in this analysis if(i)
The patient population was diagnosed with FRI according to the FRI consensus definition as shown in Figure1 [1, 28](ii)
NPWT was applied to the associated infected wound(iii)
The full article was available in the English, Dutch, or German languageFigure 1
Flowchart of confirmatory and suggestive criteria visualized by McNally et al. (2020), using the definition criteria of the FRI Consensus Group [42].


## 2.3. Exclusion Criteria

Articles were excluded from this analysis if(i)
The included study population (partly) consisted of patients with other disease entities than infected fractures (such as spondylodiscitis, diabetic feet, and pressure ulcers)(ii)
The study population concerned animals


## 2.4. Quality Assessment

The methodological quality of the selected studies was assessed using the Newcastle-Ottawa Quality Assessment Scale (NOS) [29], a tool used for assessing the quality of nonrandomized cohort and case control studies. The NOS consists of criteria organized into three categories: selection (maximum four stars), comparability (maximum two stars), and outcome (maximum three stars). A study can be awarded a maximum of nine stars. In this systematic review, an overall NOS score cutoff of ≥7 stars was defined as high quality and <7 stars as low quality. Criteria scored “N/A” were not taken into account. Only high-quality studies were included for further analysis.


## 2.5. Data Extraction and Analysis

From the high-quality papers, the following study characteristics were extracted: bibliography (first author, year of publication, country), study design, number of inclusions, patient demographics, cause of injury, type of pathogens, NPWT duration, additional treatment, final wound closure, and follow-up duration. The primary outcome was recurrence of infection.Secondary collected outcomes were wound healing time and detection of new (morphologically different) pathogens in follow-up swabs compared to the initial swab. Due to heterogeneity of studies and lack of reported outcomes, a meta-analysis could not be performed. The data was analyzed descriptively and classified according to the quality assessment.


## 3. Results

### 3.1. Included Studies

Initial database searches in PubMed (n=395), Embase (n=359), and Web of Science (n=373) resulted in 1127 potential publications. Reference list screening of the relevant articles yielded one additional article [30]. After duplicates were removed (n=352), 775 relevant articles remained for title and abstract screening which led to the exclusion of most records (n=742). The 33 remaining titles were assessed for eligibility by evaluation of the full text. Finally, 12 studies were included in the qualitative synthesis. The inclusion process is based on the PRISMA guidelines [26] and summarized in the flow diagram in Figure 2.Figure 2


### 3.2. Study Quality

The results of the methodological quality assessment are presented in Table1. The quality differed between studies. Eight studies were of high quality [30–37] (≥7 stars) and four of low quality [38–41] (<7 stars). Case reports were not assessable and therefore considered as low quality. In general, the comparability criteria scored moderately due to a wide variety in outcome measures. The overall study selection and assessment of outcomes were of good quality. The scored quality criteria can be found in Appendix II.Table 1CriteriaPatro (N=1)Li (N=18)Yikemu (N =78)Zhang (N=1)Izadpanah (N=106)Raj (N=20)Chang (N=1)Deng 2014 (N=15)Kollrack (N=7)Tan (N=35)Diefenbeck (N=43)Timmers (N=30)Selection1∗∗∗∗∗∗∗∗∗2N/A∗∗N/AN/AN/A∗N/A∗3∗∗∗∗∗∗∗∗∗4∗∗∗∗∗∗∗∗∗Comparability1a∗×∗∗∗∗∗∗∗1b××∗×∗∗∗∗∗Exposure1∗∗∗×∗∗∗∗∗2∗∗∗∗∗N/A∗∗∗3∗∗∗∗∗∗∗∗∗TotalN/A77N/A96N/A87989Patro, Zhang and Chang: Quality assessment using the Newcastle-Ottawa Quality Assessment Scale was not possible for case reports.


### 3.3. Description of Study Characteristics

Study characteristics of the eight high-quality studies, published between 2009 and 2019, are shown in Table2. Six cohort studies [31–36] and two case-control studies [30, 37] were included in this systematic review. Four of the cohort studies had a prospective [31, 34–36] and two a retrospective design [32, 33], respectively. NPWT duration varied and was often not reported. Due to small numbers of included studies, heterogeneity in applied treatment, and reported outcomes, pooling of data was not appropriate, and a meta-analysis was not possible. Hence, outcomes of the included studies [30–37] are shown in Table 3.Table 2AuthorYearCountryStudy designNPatient demographicsCause of injuryPathogensNPWT duration (days)Additional treatmentFinal wound closureFollow up (months)QualityaLi et al. [31]2019ChinaProspective longitudinal1814-57 yr, 67% ♂, no comorbidities61% traffic, 39% crushMonomicrobialUnknownAntibiotic bone cement, systemic antibioticsSkin flap transplant29.7High 7/9Yikemu et al. [35]2019ChinaProspective longitudinal7844.5±10.5 (23-68) yr, 67% ♂, no comorbidities69% traffic, 16% high fall, 10% crush, 5% otherUnknownUnknownIlizarov bone transport technique + antibiotic treatmentUnknown18.9High 7/9Izadpanah et al. [32]2017GermanyRetrospective longitudinal10654 yr (SD 19), 73% ♂, comorbiditiesUnknown20% polymicrobial, 67% monomicrobial (5.6% resistant), 13% unknownUnknownSystemic antibiotics78% secondary suture/mesh graft, 22% muscle flap>12High 9/9Deng et al. [33]2014ChinaRetrospective longitudinal1544.5 (24-68) yr, 60% ♂, comorbidities unknownMotor vehicle accidents93.3% monomicrobial (6.7% resistant), 6.7% polymicrobial25.2 (14-56)Systemic antibiotics93.3% granulation tissue, 6.7% skin graft22.6High 8/9Kollrack et al. [34]2012GermanyProspective longitudinal763.14±4.41 yr, 29% ♂, comorbiditiesUnknownMonomicrobial54.43±7.74UnknownMesh graftingN/AHigh 7/9Tan et al. [37]2011ChinaRetrospective longitudinal case-control35 (33)43.4 (18-82) yr, 74% ♂, comorbidities unknownUnknownMonomicrobial (9.4% resistant)9.2 (4-12)Antibiotic treatment47.2% muscle flap, 52.8% secondary closure15High 9/9Diefenbeck et al. [36]2011GermanyProspective longitudinal4350.7 (19-96), comorbidities unknownUnknownMonomicrobial (14.3% resistant)13.5 (10-16)Systemic antibiotics72.1% secondary closure, 14.0% skin graft, 14.0% muscle flap32-51High 8/9Timmers et al. [30]2009NLRetrospective longitudinal case-control30 (94)52 (26-81) yr, 47% ♂, 60% comorbiditiesTraumatic43.3% polymicrobial, 56.7% monomicrobial22.4 (6-60)Local antiseptic fluidUnknown43-89High 9/9aQuality assessment was performed using the Newcastle-Ottawa Quality Assessment Scale (see Table 1).Table 3AuthorYearNInfection recurrenceWound healing time (days)Pathogen changesQualityaLi et al. [31]2019185.6%UnknownUnknownHigh 7/9Yikemu et al. [35]20197824.4%35UnknownHigh 7/9Izadpanah et al. [32]201710634.9%Unknown23%High 9/9Deng et al. [33]20141513.3%35 (21-70)UnknownHigh 8/9Kollrack et al. [34]2012714.3%54.4 ± 7.70%High 7/9Tan et al. [37]2011352.8%9.2 (4-12)UnknownHigh 9/9Diefenbeck et al. [36]20114319.3%13.5 (10-16)0%High 8/9Timmers et al. [30]20093010%22.4 (6-60)0%High 9/9aQuality assessment was performed using the Newcastle-Ottawa Quality Assessment Scale (see Table 1).


### 3.4. Outcome Measures

Infection recurrence was the main outcome and was reported in all papers. Average wound healing time was stated in days and reported in six papers. Four studies repeated microbial swabs at vacuum dressings changes and reported on the detection of any new pathogens during the course of treatment [30, 32, 34, 36].


#### 3.4.1. Primary Outcome

The primary outcome parameter, FRI recurrence, was measured in all studies and ranged from 2.8% to 34.9%. The recurrence rate of 34.9% was reported in the largest and qualitatively highest rated study from Izadpanah et al. (2017,n=106). In this study, the definition of recurrent infection was based on the local and clinical situation at the time of operative revision and the outcome of intraoperative samples taken for microbiology [32]. Reinfected patients were distributed in two groups: one initially classed as having successful eradication of infection and one with ongoing infection since the baseline swab. Both groups received identical treatment including NPWT. The number of reinfections in the successful eradication group with NPWT was not significantly lower compared to patients who remained with an ongoing infection (p=0.0764), indicating that initially deemed successful treatment with NPWT had no benefit in regards to recurrence rates compared to unsuccessful eradicated infections. Yikemu et al. (2019, n=78) measured infection recurrence as main outcome and reported the second highest infection recurrence in 24.4% as pin tract infection in the course of treatment of traumatic tibial osteomyelitis [35] with Ilizarov bone transport. There is no description on how pin tract infection was diagnosed, whether it was a pin tract infection only or whether it was an expression of a more extensive FRI recurrence or neither how it was resolved. Diefenbeck et al. (2011, n=43) included patients with posttraumatic osteomyelitis of the extremities and noted six recurrences (19.3%) after 3.4 years on average [36]. Four out of these six patients had negative, and two patients had positive bone biopsies before secondary closure.Tan et al. (2011,n=35) reported a lower recurrence rate after treatment with NPWT. This study monitored infection by local symptoms, fever, and blood parameters. In the NPWT group, one reinfection was found after one month (2.8%), compared to seven (20.6%) in the conventional dressing group [37]. Additionally, Timmers et al. (2009, n=30) found 3 cases of clinical infection recurrence (10%), which was significantly lower compared to the control group with conventional dressings, with an average time to recurrence of 8 months [30]. In the study of Kollrack et al. (2012, n=7), patients who were treated with initial surgical debridement, followed by NPWT, were followed through standard radiographic scans after swabs were negative [34]. In one patient (14.3%), radiographic pseudoarthrosis was seen, due to nonunion of the medial malleolus after a trimalleolar dislocated ankle fracture. However, since most conventional radiological imaging techniques are an arbitrary method for outcome surveillance in this population, significance of this finding in regards to FRI recurrence is unclear [42].


#### 3.4.2. Secondary Outcomes

The first secondary outcome, time to wound healing, was stated in six out of eight studies but was measured in various ways. Izadpanah et al. (2017) did not describe wound healing time [32] but compared mean stay at intensive care unit (ICU) and number of lavages until assumed eradication of FRI between patients with believed cure of infection and patients with no cure of infection. No differences were found in ICU treatment, but surprisingly, more lavages were done in the assumed cured group (p=0.0431). Yikemu et al. (2019) defined wound healing, with a reported average of 35 days, as complete wound coverage with granulation tissue and no visible signs of infection [35]. Again, this is an arguable outcome measure. Wound coverage with granulation tissue only is not the robust soft tissue envelop with full epithelialization that is usually pursued [43] in FRI, and ongoing infection cannot be excluded despite a granulating wound. Deng et al. (2014) removed the NPWT device after a mean of 5 weeks, with complete coverage of the bone graft surface with granulation tissue and reported this as wound healing time [33]. In this rather small retrospective series, the mean number of vacuum dressing placements was 3.6 (range: 2-8), and the average total length of hospitalization was 3.6 months (range: 2-8). Kollrack et al. (2012) and Tan et al. (2011) defined end of treatment as the point at which a dry, clean wound was achieved, respectively, after a mean of 54.4 [34] and 9.2 [37] days. Diefenbeck et al. (2011) performed 9.8 debridements on average, until eradication of infection. Despite the absence of macroscopic infection, pathogens were still found in biopsies in 15 out of 43 patients [36]. Timmers et al. (2009) reported a mean duration of NPWT of 22.4 days per executed osteomyelitis treatment [30]. Treatment was stopped when either two consecutive swabs were sterile or when enough new granulation tissue had formed to permit successful delayed primary closure or split-thickness skin grafting.The results of repeated microbial swabs taken at later vacuum dressing changes were reported in only four out of eight studies [30, 32, 34, 36]. Initial swabs were taken before treatment during first surgical debridement, in all four studies. In Kollrack et al. (2012), initial wound swabs showed 71.4% S. aureus and 28.5% Enterococcus species [34]. All swabs were negative during the second vacuum dressing change. In the study of Diefenbeck et al. (2011), a bone specimen was taken for microscopic analysis after each revision [36]. Initial specimens showed mostly S. aureus (52.4%) and Enterococcus (21.4%). No polymicrobial infections or detection of new (morphological different) pathogens were reported. In the study of Timmers et al. (2009), deep wound swabs were taken during dressing changes, every 3-4 days [30]. The NPWT was ended if two consecutive swabs were negative or showed skin bacteria only. In total, 72 bacterial species were identified, including S. aureus (40.3%) and E. cloacae (12.5%). Thirteen patients were identified with a polymicrobial infection. Although three recurrences occurred, no new pathogens were identified. In the study of Izadpanah et al. (2017), in 87% of all patients, bacteria were isolated during primary lavage, with the largest groups consisting of S. aureus (39.6%) and Staphylococcus epidermis (11.3%). A polymicrobial infection was present in 20% of the cases. The primary presence of a pathogen did not influence treatment failure (p=0.2016); although, it increased the risk of losing the implant before fracture consolidation (p=0.0413). The pathogen profile changed under therapy in 23% of all cases. It is unclear whether this also concerned increased antibiotic resistance or not. Izadpanah et al. (2017) stated that the identification of new pathogens during treatment does increase the risk for treatment failure (p=0.0047).


## 3.1. Included Studies

Initial database searches in PubMed (n=395), Embase (n=359), and Web of Science (n=373) resulted in 1127 potential publications. Reference list screening of the relevant articles yielded one additional article [30]. After duplicates were removed (n=352), 775 relevant articles remained for title and abstract screening which led to the exclusion of most records (n=742). The 33 remaining titles were assessed for eligibility by evaluation of the full text. Finally, 12 studies were included in the qualitative synthesis. The inclusion process is based on the PRISMA guidelines [26] and summarized in the flow diagram in Figure 2.Figure 2


## 3.2. Study Quality

The results of the methodological quality assessment are presented in Table1. The quality differed between studies. Eight studies were of high quality [30–37] (≥7 stars) and four of low quality [38–41] (<7 stars). Case reports were not assessable and therefore considered as low quality. In general, the comparability criteria scored moderately due to a wide variety in outcome measures. The overall study selection and assessment of outcomes were of good quality. The scored quality criteria can be found in Appendix II.Table 1CriteriaPatro (N=1)Li (N=18)Yikemu (N =78)Zhang (N=1)Izadpanah (N=106)Raj (N=20)Chang (N=1)Deng 2014 (N=15)Kollrack (N=7)Tan (N=35)Diefenbeck (N=43)Timmers (N=30)Selection1∗∗∗∗∗∗∗∗∗2N/A∗∗N/AN/AN/A∗N/A∗3∗∗∗∗∗∗∗∗∗4∗∗∗∗∗∗∗∗∗Comparability1a∗×∗∗∗∗∗∗∗1b××∗×∗∗∗∗∗Exposure1∗∗∗×∗∗∗∗∗2∗∗∗∗∗N/A∗∗∗3∗∗∗∗∗∗∗∗∗TotalN/A77N/A96N/A87989Patro, Zhang and Chang: Quality assessment using the Newcastle-Ottawa Quality Assessment Scale was not possible for case reports.


## 3.3. Description of Study Characteristics

Study characteristics of the eight high-quality studies, published between 2009 and 2019, are shown in Table2. Six cohort studies [31–36] and two case-control studies [30, 37] were included in this systematic review. Four of the cohort studies had a prospective [31, 34–36] and two a retrospective design [32, 33], respectively. NPWT duration varied and was often not reported. Due to small numbers of included studies, heterogeneity in applied treatment, and reported outcomes, pooling of data was not appropriate, and a meta-analysis was not possible. Hence, outcomes of the included studies [30–37] are shown in Table 3.Table 2AuthorYearCountryStudy designNPatient demographicsCause of injuryPathogensNPWT duration (days)Additional treatmentFinal wound closureFollow up (months)QualityaLi et al. [31]2019ChinaProspective longitudinal1814-57 yr, 67% ♂, no comorbidities61% traffic, 39% crushMonomicrobialUnknownAntibiotic bone cement, systemic antibioticsSkin flap transplant29.7High 7/9Yikemu et al. [35]2019ChinaProspective longitudinal7844.5±10.5 (23-68) yr, 67% ♂, no comorbidities69% traffic, 16% high fall, 10% crush, 5% otherUnknownUnknownIlizarov bone transport technique + antibiotic treatmentUnknown18.9High 7/9Izadpanah et al. [32]2017GermanyRetrospective longitudinal10654 yr (SD 19), 73% ♂, comorbiditiesUnknown20% polymicrobial, 67% monomicrobial (5.6% resistant), 13% unknownUnknownSystemic antibiotics78% secondary suture/mesh graft, 22% muscle flap>12High 9/9Deng et al. [33]2014ChinaRetrospective longitudinal1544.5 (24-68) yr, 60% ♂, comorbidities unknownMotor vehicle accidents93.3% monomicrobial (6.7% resistant), 6.7% polymicrobial25.2 (14-56)Systemic antibiotics93.3% granulation tissue, 6.7% skin graft22.6High 8/9Kollrack et al. [34]2012GermanyProspective longitudinal763.14±4.41 yr, 29% ♂, comorbiditiesUnknownMonomicrobial54.43±7.74UnknownMesh graftingN/AHigh 7/9Tan et al. [37]2011ChinaRetrospective longitudinal case-control35 (33)43.4 (18-82) yr, 74% ♂, comorbidities unknownUnknownMonomicrobial (9.4% resistant)9.2 (4-12)Antibiotic treatment47.2% muscle flap, 52.8% secondary closure15High 9/9Diefenbeck et al. [36]2011GermanyProspective longitudinal4350.7 (19-96), comorbidities unknownUnknownMonomicrobial (14.3% resistant)13.5 (10-16)Systemic antibiotics72.1% secondary closure, 14.0% skin graft, 14.0% muscle flap32-51High 8/9Timmers et al. [30]2009NLRetrospective longitudinal case-control30 (94)52 (26-81) yr, 47% ♂, 60% comorbiditiesTraumatic43.3% polymicrobial, 56.7% monomicrobial22.4 (6-60)Local antiseptic fluidUnknown43-89High 9/9aQuality assessment was performed using the Newcastle-Ottawa Quality Assessment Scale (see Table 1).Table 3AuthorYearNInfection recurrenceWound healing time (days)Pathogen changesQualityaLi et al. [31]2019185.6%UnknownUnknownHigh 7/9Yikemu et al. [35]20197824.4%35UnknownHigh 7/9Izadpanah et al. [32]201710634.9%Unknown23%High 9/9Deng et al. [33]20141513.3%35 (21-70)UnknownHigh 8/9Kollrack et al. [34]2012714.3%54.4 ± 7.70%High 7/9Tan et al. [37]2011352.8%9.2 (4-12)UnknownHigh 9/9Diefenbeck et al. [36]20114319.3%13.5 (10-16)0%High 8/9Timmers et al. [30]20093010%22.4 (6-60)0%High 9/9aQuality assessment was performed using the Newcastle-Ottawa Quality Assessment Scale (see Table 1).


## 3.4. Outcome Measures

Infection recurrence was the main outcome and was reported in all papers. Average wound healing time was stated in days and reported in six papers. Four studies repeated microbial swabs at vacuum dressings changes and reported on the detection of any new pathogens during the course of treatment [30, 32, 34, 36].


### 3.4.1. Primary Outcome

The primary outcome parameter, FRI recurrence, was measured in all studies and ranged from 2.8% to 34.9%. The recurrence rate of 34.9% was reported in the largest and qualitatively highest rated study from Izadpanah et al. (2017,n=106). In this study, the definition of recurrent infection was based on the local and clinical situation at the time of operative revision and the outcome of intraoperative samples taken for microbiology [32]. Reinfected patients were distributed in two groups: one initially classed as having successful eradication of infection and one with ongoing infection since the baseline swab. Both groups received identical treatment including NPWT. The number of reinfections in the successful eradication group with NPWT was not significantly lower compared to patients who remained with an ongoing infection (p=0.0764), indicating that initially deemed successful treatment with NPWT had no benefit in regards to recurrence rates compared to unsuccessful eradicated infections. Yikemu et al. (2019, n=78) measured infection recurrence as main outcome and reported the second highest infection recurrence in 24.4% as pin tract infection in the course of treatment of traumatic tibial osteomyelitis [35] with Ilizarov bone transport. There is no description on how pin tract infection was diagnosed, whether it was a pin tract infection only or whether it was an expression of a more extensive FRI recurrence or neither how it was resolved. Diefenbeck et al. (2011, n=43) included patients with posttraumatic osteomyelitis of the extremities and noted six recurrences (19.3%) after 3.4 years on average [36]. Four out of these six patients had negative, and two patients had positive bone biopsies before secondary closure.Tan et al. (2011,n=35) reported a lower recurrence rate after treatment with NPWT. This study monitored infection by local symptoms, fever, and blood parameters. In the NPWT group, one reinfection was found after one month (2.8%), compared to seven (20.6%) in the conventional dressing group [37]. Additionally, Timmers et al. (2009, n=30) found 3 cases of clinical infection recurrence (10%), which was significantly lower compared to the control group with conventional dressings, with an average time to recurrence of 8 months [30]. In the study of Kollrack et al. (2012, n=7), patients who were treated with initial surgical debridement, followed by NPWT, were followed through standard radiographic scans after swabs were negative [34]. In one patient (14.3%), radiographic pseudoarthrosis was seen, due to nonunion of the medial malleolus after a trimalleolar dislocated ankle fracture. However, since most conventional radiological imaging techniques are an arbitrary method for outcome surveillance in this population, significance of this finding in regards to FRI recurrence is unclear [42].


### 3.4.2. Secondary Outcomes

The first secondary outcome, time to wound healing, was stated in six out of eight studies but was measured in various ways. Izadpanah et al. (2017) did not describe wound healing time [32] but compared mean stay at intensive care unit (ICU) and number of lavages until assumed eradication of FRI between patients with believed cure of infection and patients with no cure of infection. No differences were found in ICU treatment, but surprisingly, more lavages were done in the assumed cured group (p=0.0431). Yikemu et al. (2019) defined wound healing, with a reported average of 35 days, as complete wound coverage with granulation tissue and no visible signs of infection [35]. Again, this is an arguable outcome measure. Wound coverage with granulation tissue only is not the robust soft tissue envelop with full epithelialization that is usually pursued [43] in FRI, and ongoing infection cannot be excluded despite a granulating wound. Deng et al. (2014) removed the NPWT device after a mean of 5 weeks, with complete coverage of the bone graft surface with granulation tissue and reported this as wound healing time [33]. In this rather small retrospective series, the mean number of vacuum dressing placements was 3.6 (range: 2-8), and the average total length of hospitalization was 3.6 months (range: 2-8). Kollrack et al. (2012) and Tan et al. (2011) defined end of treatment as the point at which a dry, clean wound was achieved, respectively, after a mean of 54.4 [34] and 9.2 [37] days. Diefenbeck et al. (2011) performed 9.8 debridements on average, until eradication of infection. Despite the absence of macroscopic infection, pathogens were still found in biopsies in 15 out of 43 patients [36]. Timmers et al. (2009) reported a mean duration of NPWT of 22.4 days per executed osteomyelitis treatment [30]. Treatment was stopped when either two consecutive swabs were sterile or when enough new granulation tissue had formed to permit successful delayed primary closure or split-thickness skin grafting.The results of repeated microbial swabs taken at later vacuum dressing changes were reported in only four out of eight studies [30, 32, 34, 36]. Initial swabs were taken before treatment during first surgical debridement, in all four studies. In Kollrack et al. (2012), initial wound swabs showed 71.4% S. aureus and 28.5% Enterococcus species [34]. All swabs were negative during the second vacuum dressing change. In the study of Diefenbeck et al. (2011), a bone specimen was taken for microscopic analysis after each revision [36]. Initial specimens showed mostly S. aureus (52.4%) and Enterococcus (21.4%). No polymicrobial infections or detection of new (morphological different) pathogens were reported. In the study of Timmers et al. (2009), deep wound swabs were taken during dressing changes, every 3-4 days [30]. The NPWT was ended if two consecutive swabs were negative or showed skin bacteria only. In total, 72 bacterial species were identified, including S. aureus (40.3%) and E. cloacae (12.5%). Thirteen patients were identified with a polymicrobial infection. Although three recurrences occurred, no new pathogens were identified. In the study of Izadpanah et al. (2017), in 87% of all patients, bacteria were isolated during primary lavage, with the largest groups consisting of S. aureus (39.6%) and Staphylococcus epidermis (11.3%). A polymicrobial infection was present in 20% of the cases. The primary presence of a pathogen did not influence treatment failure (p=0.2016); although, it increased the risk of losing the implant before fracture consolidation (p=0.0413). The pathogen profile changed under therapy in 23% of all cases. It is unclear whether this also concerned increased antibiotic resistance or not. Izadpanah et al. (2017) stated that the identification of new pathogens during treatment does increase the risk for treatment failure (p=0.0047).


## 3.4.1. Primary Outcome

The primary outcome parameter, FRI recurrence, was measured in all studies and ranged from 2.8% to 34.9%. The recurrence rate of 34.9% was reported in the largest and qualitatively highest rated study from Izadpanah et al. (2017,n=106). In this study, the definition of recurrent infection was based on the local and clinical situation at the time of operative revision and the outcome of intraoperative samples taken for microbiology [32]. Reinfected patients were distributed in two groups: one initially classed as having successful eradication of infection and one with ongoing infection since the baseline swab. Both groups received identical treatment including NPWT. The number of reinfections in the successful eradication group with NPWT was not significantly lower compared to patients who remained with an ongoing infection (p=0.0764), indicating that initially deemed successful treatment with NPWT had no benefit in regards to recurrence rates compared to unsuccessful eradicated infections. Yikemu et al. (2019, n=78) measured infection recurrence as main outcome and reported the second highest infection recurrence in 24.4% as pin tract infection in the course of treatment of traumatic tibial osteomyelitis [35] with Ilizarov bone transport. There is no description on how pin tract infection was diagnosed, whether it was a pin tract infection only or whether it was an expression of a more extensive FRI recurrence or neither how it was resolved. Diefenbeck et al. (2011, n=43) included patients with posttraumatic osteomyelitis of the extremities and noted six recurrences (19.3%) after 3.4 years on average [36]. Four out of these six patients had negative, and two patients had positive bone biopsies before secondary closure.Tan et al. (2011,n=35) reported a lower recurrence rate after treatment with NPWT. This study monitored infection by local symptoms, fever, and blood parameters. In the NPWT group, one reinfection was found after one month (2.8%), compared to seven (20.6%) in the conventional dressing group [37]. Additionally, Timmers et al. (2009, n=30) found 3 cases of clinical infection recurrence (10%), which was significantly lower compared to the control group with conventional dressings, with an average time to recurrence of 8 months [30]. In the study of Kollrack et al. (2012, n=7), patients who were treated with initial surgical debridement, followed by NPWT, were followed through standard radiographic scans after swabs were negative [34]. In one patient (14.3%), radiographic pseudoarthrosis was seen, due to nonunion of the medial malleolus after a trimalleolar dislocated ankle fracture. However, since most conventional radiological imaging techniques are an arbitrary method for outcome surveillance in this population, significance of this finding in regards to FRI recurrence is unclear [42].


## 3.4.2. Secondary Outcomes

The first secondary outcome, time to wound healing, was stated in six out of eight studies but was measured in various ways. Izadpanah et al. (2017) did not describe wound healing time [32] but compared mean stay at intensive care unit (ICU) and number of lavages until assumed eradication of FRI between patients with believed cure of infection and patients with no cure of infection. No differences were found in ICU treatment, but surprisingly, more lavages were done in the assumed cured group (p=0.0431). Yikemu et al. (2019) defined wound healing, with a reported average of 35 days, as complete wound coverage with granulation tissue and no visible signs of infection [35]. Again, this is an arguable outcome measure. Wound coverage with granulation tissue only is not the robust soft tissue envelop with full epithelialization that is usually pursued [43] in FRI, and ongoing infection cannot be excluded despite a granulating wound. Deng et al. (2014) removed the NPWT device after a mean of 5 weeks, with complete coverage of the bone graft surface with granulation tissue and reported this as wound healing time [33]. In this rather small retrospective series, the mean number of vacuum dressing placements was 3.6 (range: 2-8), and the average total length of hospitalization was 3.6 months (range: 2-8). Kollrack et al. (2012) and Tan et al. (2011) defined end of treatment as the point at which a dry, clean wound was achieved, respectively, after a mean of 54.4 [34] and 9.2 [37] days. Diefenbeck et al. (2011) performed 9.8 debridements on average, until eradication of infection. Despite the absence of macroscopic infection, pathogens were still found in biopsies in 15 out of 43 patients [36]. Timmers et al. (2009) reported a mean duration of NPWT of 22.4 days per executed osteomyelitis treatment [30]. Treatment was stopped when either two consecutive swabs were sterile or when enough new granulation tissue had formed to permit successful delayed primary closure or split-thickness skin grafting.The results of repeated microbial swabs taken at later vacuum dressing changes were reported in only four out of eight studies [30, 32, 34, 36]. Initial swabs were taken before treatment during first surgical debridement, in all four studies. In Kollrack et al. (2012), initial wound swabs showed 71.4% S. aureus and 28.5% Enterococcus species [34]. All swabs were negative during the second vacuum dressing change. In the study of Diefenbeck et al. (2011), a bone specimen was taken for microscopic analysis after each revision [36]. Initial specimens showed mostly S. aureus (52.4%) and Enterococcus (21.4%). No polymicrobial infections or detection of new (morphological different) pathogens were reported. In the study of Timmers et al. (2009), deep wound swabs were taken during dressing changes, every 3-4 days [30]. The NPWT was ended if two consecutive swabs were negative or showed skin bacteria only. In total, 72 bacterial species were identified, including S. aureus (40.3%) and E. cloacae (12.5%). Thirteen patients were identified with a polymicrobial infection. Although three recurrences occurred, no new pathogens were identified. In the study of Izadpanah et al. (2017), in 87% of all patients, bacteria were isolated during primary lavage, with the largest groups consisting of S. aureus (39.6%) and Staphylococcus epidermis (11.3%). A polymicrobial infection was present in 20% of the cases. The primary presence of a pathogen did not influence treatment failure (p=0.2016); although, it increased the risk of losing the implant before fracture consolidation (p=0.0413). The pathogen profile changed under therapy in 23% of all cases. It is unclear whether this also concerned increased antibiotic resistance or not. Izadpanah et al. (2017) stated that the identification of new pathogens during treatment does increase the risk for treatment failure (p=0.0047).


## 4. Discussion

The aim of this study was to qualitatively assess the current literature on the role of NPWT in FRI treatment with focus on recurrence rate, the detection of new pathogens at subsequent dressing changes, and time to wound healing.Despite the claim that NPWT for the management of soft tissue defects can contribute to fast and safe infection control [15, 44], based on the best available evidence presented in this paper, the overall infection recurrence of FRI treated with NPWT ranges from 2.8% up to 34.9% [30–37]. In this perspective, several caveats should be considered. Not all studies reported on how infection recurrence was diagnosed, differences in soft tissue defects were not classified in FRI, and groups were heterogeneous in regards to clinical presentation and location of FRI. Izadpanah et al. (2017) published the highest incidence of infection recurrence (34.9%) [32]. This study consisted of the largest study population (n=106) and yielded the highest quality assessment score. In general, inconsistent methods were used to diagnose FRI, such as debatable clinical infection parameters or imaging techniques [1, 42]. For instance, Diefenbeck et al. (2011) performed final wound closure after the absence of macroscopic infection [36], and Timmers et al. (2009) stopped treatment based on negative swaps [30], while Izadpanah et al. (2017) used a combination of clinical features and intraoperative samples for microbiological assessment [32], which is a more reliable diagnostic method [1, 45]. Overall, recurrence rates of FRI after treatment with NPWT are widespread and inconsistent.Other findings were the high number of reported reoperations with the sole purpose of vacuum dressing changes (with means ranging from 1 to 10 changes) and the long period of hospitalization (with reported means ranging from 1.5 to 8 weeks). This does not support the view that NPWT encourages rapid wound healing. Also, it will increase the cost of care in this, already costly, disease.Although scientific evidence on the use of NPWT in case of FRI is scarce, data focusing on the use of NPWT in open fractures is abundant. With earlier studies showing promising results, many subsequent trials could not replicate the initial positive outcomes. The recent WOLFF randomized trial, for example, demonstrated that there was no benefit of NPWT compared to standard wound care in 460 patients with an open fracture of the lower limb [46]. Also, a systematic review, based on seven randomized controlled trials, found that there is moderate evidence that there is no difference between NPWT and standard care in open fractures with respect to wound healing [47]. Furthermore, the FLOW trial reported an increased infection rate in all types of open fracture wounds after treatment with NPWT [48]. This evidence applies to the primary care of open fractures, which is rather different to established FRI with a soft tissue defect. The initial enthusiasm for NPWT in open fractures may not be appropriate in FRI management.The average time needed for wound healing reported in this review ranged from 1.5 to 7 weeks [30, 33–37]. Kollrack et al. (2012) reported the highest mean of 54 (±8) days, probably since their included patients were diagnosed with angiopathy with compromised local microcirculation [34]. Nonetheless, their reported wound healing time of approximately five weeks was considered to be promising compared to the ≥12 weeks for traditional open bone grafting (the so-called Papineau technique) [49, 50]. Having said this, the Papineau technique is nowadays rarely performed due to the negative side effects related to the long period of open wound care with exposed bone grafts.It is argued that NPWT can significantly reduce the wound surface area [39, 41, 51] and provide stable wound healing [52]. Although this might well apply for soft tissue defects only, in case of FRI, expert opinion strongly advises against the prolonged use of NPWT in this patient population [53]. The current opinion is to aim for robust and early soft tissue coverage by local or free tissue transfers to prevent further contamination and to promote tissue vascularization for antibiotic delivery and bone healing [54–56]. Experts state that the longer final coverage is delayed by NPWT, and the more wound edges and surrounding soft tissues will become negatively affected. Tissue formed under NPWT can evolve into more rigid and difficult-to-handle scar and granulation tissue which can hamper the final reconstruction for both muscle and fasciocutaneous flap inset [57]. Also, the formed granulation tissue is often of poor quality. It may need to be removed at the time of definitive reconstruction, negating any benefit from the period of NPWT [56]. Based on the results of this review, we can add the argument of high FRI recurrence rates (up to 34.9%) to this opinion.S. aureus is the most common bacterium causing FRI in the studies included in this review, followed by S. epidermidis and E. faecalis [30, 32, 34, 58, 59]. This is in line with the common pathogens usually identified in FRI [60, 61]. Four included studies stated that NPWT can help infectious wounds heal regardless of the microbial characteristics [30, 34, 62, 63]. However, Izadpanah et al. (2017) stated that if new pathogens were identified during NPWT, the risk of treatment failure rose significantly [32]. These results concur with findings from a previous randomized trial by Mouës et al. (2004), who found that NPWT creates a shift with a decrease in nonfermented negative rods to an increase in S. aureus [23] in 54 patients who underwent either open wound management or NPWT before surgical closure of their wounds. Other included studies did not report a change in microbial strains [30, 34, 36]. To summarize, differing outcomes have been reported; therefore, more research targeting this topic is needed to understand the exact pathogen evolution in FRI patients undergoing NPWT.In future research on the optimal management of soft tissue defects in FRI patients, it is essential that prospective clinical studies with large sample sizes and validated patient-reported outcome measures become available. Furthermore, it is necessary to include a grading system considering differences in soft tissue defects, such as the BACH classification [64]. Besides, diagnostics of FRI should not rely on swab cultures, since better techniques are well established [45]. A special focus on infection recurrence and utilization of medical care is needed, to reliably compare the results of NPWT with other wound closure techniques such as local or free tissue transfers in this patient category.


## 5. Limitations

Firstly, the main disadvantage of this systematic review is the limited number of high-quality studies on FRI treatment with NPWT. Secondly, there was a lack of uniformity in NPWT use and additional treatment, final wound closure, and measured outcomes between the included studies. Also, included studies sampled with swabs and the total number of patients were low while the variation between studies was wide. Therefore, this review could only provide limited evidence.


## 6. Conclusion

This review provides an assessment of current literature on the role of NPWT in the management of soft tissue defects in patients with FRI. Due to the lack of uniformity in included studies, conclusions should be drawn with caution. Currently, there is no clear scientific evidence to support the use of NPWT as definitive treatment in FRI. At this stage, we can only recommend early soft tissue coverage (within days) with a local or free flap. NPWT may be safe for a few days as temporarily soft tissue coverage until definitive soft tissue management could be performed. However, comparative studies between NPWT and early wound closure in FRI patients are needed.



---

*Source: 7742227-2021-10-19.xml*